Equillium Inc (EQ)
1.51
-0.03
(-1.95%)
USD |
NASDAQ |
May 15, 15:51
Equillium Profit Margin (Quarterly): -25.58% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -25.58% |
| December 31, 2023 | -25.43% |
| September 30, 2023 | -41.83% |
| Date | Value |
|---|---|
| June 30, 2023 | -36.64% |
| March 31, 2023 | -44.37% |
| December 31, 2022 | 17.60% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-44.37%
Minimum
Mar 2023
17.60%
Maximum
Dec 2022
-26.04%
Average
-31.11%
Median
Profit Margin (Quarterly) Benchmarks
| Janux Therapeutics Inc | -1.18K% |
| Mersana Therapeutics Inc | -208.8% |
| Vera Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -122.2% |
| Palatin Technologies Inc | -385.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.90% |
| Return on Assets | -21.67% |
| Return on Invested Capital | -46.09% |
| Operating Margin (Quarterly) | -26.11% |
| Return on Net Operating Assets | -171.8% |